Enrico Zanardo
![Enrico Zanardo](/globalassets/experts-and-consultants/vice-presidents/zanardo_enrico.jpg)
Education
Ph.D. and M.Phil., economics, Columbia University; M.S., applied mathematics, and B.A., mathematics, University of Padua, Italy
Summary of Experience
Dr. Zanardo specializes in health care economics, with expertise in developing economic and statistical models to assess health outcomes, treatment patterns, and the economic burden of diseases across a diverse range of therapeutic areas, including psychiatry, dermatology, hematology, and oncology. His client work bridges rigorous academic research and practical applications in real-world evidence (RWE) generation and market access strategy. Dr. Zanardo has extensive experience analyzing health care resource utilization and costs using real-world data (RWD) sources such as medical and pharmacy claims, surveys to collect patient-reported outcomes (PROs), and literature reviews to evaluate disease prevalence and treatment landscapes. He has also assisted pharmaceutical companies in evaluating the clinical and economic benefits associated with their products to improve marketability and access in competitive markets. Dr. Zanardo has applied advanced analytic techniques, including predictive modeling and machine learning, to generate insights that inform decision making for clients.
-
Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study
Leukemia Research, 2025
2025Andritsos LA, McBride A, Tang D, Barghout V, Zanardo E, Song R, Huynh L, Yenikomshian M, Makinde AY, Hughes C, Hanna KS, Patel K
-
Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US
The Oncologist, 2024
2024Yang X, Zanardo E, Lejeune D, De Nigris E, Sarpong E, Farooqui M, Laliberté F
-
Impact of formulary-related pharmacy claim rejections of cariprazine on health care utilization and treatment patterns among patients with bipolar I disorder
Journal of Managed Care & Specialty Pharmacy, 2024
2024Laliberté F, Zanardo E, MacKnight SD, Urosevic A, Wade SW, Parikh M
-
Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinib
Future Oncology, October 2024
2024De Nigris E, Yang X, Zanardo E, Lejeune D, Farooqui MZH, Gandra SR, Laliberté F
-
Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer
Clinical Genitourinary Cancer, 2024
2024DerSarkissian M, Arondekar B, Gupta D, Ivanova J, Niyazov A, Zanardo E, Guo T, Wang J, Duh MS, Freedland SJ
-
Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
BMC Ophthalmology, 2023
2023Karpecki P, Barghout V, Schenkel B, Huynh L, Khanal A, Mitchell B, Yenikomshian M, Zanardo E, Matossian C
-
January 3, 2025
-
November 4, 2024
-
December 1, 2023
-
March 2, 2023
-
December 7, 2022